Manuel Adolfo
Sánchez Martín
Profesor Titular de Universidad
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (11)
2023
-
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Molecular cancer, Vol. 22, Núm. 1, pp. 119
-
N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer
Oncogene, Vol. 42, Núm. 43, pp. 3169-3181
2022
-
CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance
Frontiers in Cell and Developmental Biology, Vol. 10
-
Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration
Cancers, Vol. 14, Núm. 16
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Characterization of the platelet phenotype caused by a germline RUNX1 Variant in a CRISPR/Cas9-generated murine model
Thrombosis and Haemostasis, Vol. 121, Núm. 9, pp. 1193-1205
2019
-
MEK5 promotes lung adenocarcinoma
The European respiratory journal
-
Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency
PLoS ONE, Vol. 14, Núm. 5
2017
-
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040